Clinical trial
Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
NCT00588731
Study timeline
Study start (unknown)2009-02-01Date precision: month
Registry last updated2017-06-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
CannabidiolDRUG · verified · RxNorm: cannabidiol
PlaceboDRUG
Sponsors & collaborators
Yale Universitylead sponsor
Stanley Medical Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00588731 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.